BioVerum Partners augments in-house resources in all aspects of evaluating, selling, acquiring, and collaborating on the development of strategic assets. We support acquisition and divestiture plans with solid research, justification, and financial considerations. BioVerum Partners provides clients with a negotiation team of legal, technical, and financial experts to create, execute, and manage acquisition and divestiture negotiating strategies. From a comprehensive assessment of the market to a robust evaluation of new business opportunities, we provide all of the capabilities required to achieve a value-creating partnership. Services include comprehensive due diligence, valuation assessment, product dossiers, negotiation, and alliance management. We provide clients access to an unmatched network of industry leaders, scientific experts, government officials, and academicians. Access to these individuals provides a source for intelligence and strategy not readily accessible in the public domain.

BioVerum is a “one-stop shop” for the analysis of healthcare investment opportunities. From intellectual property platform to technical feasibility to market opportunity, our experts provide a comprehensive report to support investment decisions. Post-investment, BioVerum Partners can be tapped to expedite value creation in portfolio companies – formulating and executing on competitive product development and business development strategies.